Journal article
Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part I)
Clinical pharmacokinetics, Vol.22(3), pp.211-222
03/1992
DOI: 10.2165/00003088-199222030-00003
PMID: 1559312
Abstract
Positron emission tomography (PET) involves imaging the biodistribution and tissue localisation of small amounts of radiolabelled biomolecules or drugs. In Part I of this article, the applications of pharmacokinetics in PET are discussed in order to derive quantitative measures of physiological function. Part II will examine the use of PET imaging as a tool to study the pharmacokinetics and pharmacodynamics of specific drugs.
Details
- Title: Subtitle
- Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part I)
- Creators
- L L Ponto - Department of Radiology, University of Iowa, Iowa CityJ A Ponto
- Resource Type
- Journal article
- Publication Details
- Clinical pharmacokinetics, Vol.22(3), pp.211-222
- Publisher
- Switzerland
- DOI
- 10.2165/00003088-199222030-00003
- PMID
- 1559312
- ISSN
- 0312-5963
- eISSN
- 1179-1926
- Language
- English
- Date published
- 03/1992
- Academic Unit
- Radiology; Pharmaceutical Sciences and Experimental Therapeutics; Pharmacy Practice and Science
- Record Identifier
- 9984051731602771
Metrics
14 Record Views